The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Will The Market Value Of The C-Reactive Protein Testing Market Grow Between 2026 And 2030?
The c-reactive protein testing market has experienced significant expansion in recent years. It is anticipated to grow from $3.52 billion in 2025 to $3.7 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.1%. This historical growth can be attributed to factors such as the increasing prevalence of inflammatory diseases, the rising application of CRP testing in clinical diagnostics, the expansion of hospital laboratory infrastructure, growing awareness regarding early disease detection, and the availability of standardized assay kits.
The c-reactive protein testing market is projected to experience consistent expansion over the upcoming years. Its valuation is anticipated to reach $4.48 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.9%. Factors contributing to this growth during the projected period include the rising need for point-of-care inflammatory testing, the growing incorporation of automated diagnostics platforms, the broadening scope of preventive healthcare screening, the increasing uptake of high-throughput laboratory systems, and a heightened emphasis on personalized medicine diagnostics. Key trends observed throughout the forecast timeframe encompass the expanding embrace of high-sensitivity CRP assays, the increased utilization of automated immunoassay systems, the escalating requirement for rapid inflammation diagnostics, the wider application of CRP testing in cardiovascular risk evaluation, and a stronger emphasis on automating laboratory workflows.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6719&type=smp
What Leading Drivers Are Supporting The C-Reactive Protein Testing Market Expansion?
The rising incidence of cardiovascular diseases (CVD) is anticipated to drive the c-reactive protein testing market forward. These conditions encompass various heart ailments, including diseased vessels, structural problems, and blood clots. While the precise cause of CVD is not fully understood, numerous factors elevate the risk of its development. Behavioral risks, such as unbalanced eating, insufficient physical activity, smoking, and alcohol consumption, are key contributors, leading to the accumulation of fatty deposits inside arteries (atherosclerosis) and an increased likelihood of blood clots. These behavioral factors also result in elevated blood pressure, glucose, blood lipids, weight gain, and obesity. The growing number of cardiovascular disease cases underscores the necessity for c-reactive protein testing to diagnose or predict cardiovascular problems, performing at least as effectively as cholesterol level assessments. For instance, according to data from October 2024 provided by the Centers for Disease Control, a US-based government agency, approximately 919,032 people died from cardiovascular disease in 2023, accounting for 1 in every 3 deaths. Consequently, the increasing prevalence of cardiovascular diseases (CVD) is propelling the c-reactive protein testing market.
What Segment Categories Shape The C-Reactive Protein Testing Market Segment Landscape?
The c-reactive protein testing market covered in this report is segmented –
1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays
2) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications
3) By End Use: Clinics, Hospitals, Diagnostic Laboratories
Subsegments:
1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA
2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA, Automated CLIA Systems
3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays, Latex Agglutination Immunoturbidimetric Assays
What Emerging Trends Are Seen In The C-Reactive Protein Testing Market?
Leading companies within the C-reactive protein testing market are prioritizing the development of technological advancements, such as high-sensitivity automated immunoassays, to achieve more accurate, rapid, and low-level CRP detection. This focus aims to support early cardiovascular risk stratification and real-time inflammation monitoring. High-sensitivity automated immunoassays employ sophisticated immunoturbidimetric or nephelometric techniques to identify very low CRP levels, substantially below those detectable by standard CRP assays, thereby enabling earlier intervention and improved prognostic evaluations. For instance, in January 2024, Siemens Healthineers, a Germany-based in vitro diagnostics company, launched the Atellica CH High Sensitivity C-Reactive Protein 2 (hCRP2) assay for its Atellica CH Analyzer. This product features two ready-to-use reagent packs: one containing a phosphate buffer with surfactant, and the other holding monoclonal anti-CRP antibodies bound to polystyrene particles. When CRP in a patient sample causes these particles to aggregate, the resulting light scattering is measured, with its intensity directly proportional to the CRP concentration. The system facilitates very low-level CRP detection for cardiovascular risk stratification, is compatible with serum or plasma samples, and provides rapid quantitative results, aiding in timely clinical decision-making.
Who Are The Companies Operating Across The C-Reactive Protein Testing Market Value Chain?
Major companies operating in the c-reactive protein testing market are Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMérieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation
Get The Full C-Reactive Protein Testing Market Report:
https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report
Which Region Is The Top Contributor To The C-Reactive Protein Testing Market By Share?
North America was the largest region in the c-reactive protein testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized C-Reactive Protein Testing Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=6719&type=smp
Browse Through More Reports Similar to the Global C-Reactive Protein Testing Market 2026, By The Business Research Company
Packaged Salad Market Report 2026
https://www.thebusinessresearchcompany.com/report/packaged-salad-global-market-report
Packaged Sunflower Seeds Market Report 2026
https://www.thebusinessresearchcompany.com/report/packaged-sunflower-seeds-global-market-report
Packaged Wastewater Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/packaged-wastewater-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model